ARTICLE | Emerging Company Profile
Acorda Therapeutics Inc.
January 3, 1997 8:00 AM UTC
New York, N.Y.
Technology: 4-aminopyridine potassium channel blocker; myelinating monoclonal antibodies; cellular adhesion molecules for neuroregeneration, and antioxidant drug cocktail...